Stock data
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT) reported revenue of US$81.36M and net income of -US$142.62M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$81.36M | — | -US$121.50M | -US$142.62M | — |
| 2024 | US$70.84M | — | -US$130.65M | -US$157.85M | — |
| 2023 | US$69.06M | — | -US$165.99M | -US$240.05M | — |
| 2022 | US$74.91M | — | -US$123.34M | -US$157.13M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$18.63M | -US$16.57M | — |
| 2026-03-31 | US$20.03M | -US$32.97M | — |
| 2025-12-31 | US$30.12M | -US$6.41M | — |
| 2025-09-30 | US$15.75M | -US$40.97M | — |
| 2025-06-30 | US$18.09M | -US$56.65M | — |
| 2025-03-31 | US$17.40M | -US$38.60M | — |
| 2024-12-31 | US$17.94M | -US$30.73M | — |
| 2024-09-30 | US$18.02M | -US$43.97M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.